Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report

July 2018 | 39 pages | ID: B7D33D96D8AEN
MarketLine

Abstracts

Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report

Summary

Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bayer HealthCare Pharmaceuticals,(Bayer Healthcare or 'the company'), a subsidiary of Bayer AG is involved in development and commercialization of drugs in cardiovascular and blood diseases, oncology, ophthalmology and women's healthcare. The company offers cardiovascular and blood disorder treatment drugs, women healthcare products, contraceptives, erectile dysfunction medicines, testosterone deficiency treatment and ophthalmology products. It also offers oncology products, hematology drug, multiple sclerosis treatment drugs, diabetes treatment drugs, drugs for treatment of infectious diseases (respiratory tract infections, urinary-tract infections, serious skin infections), diagnostic imaging equipment and contrast agents. Bayer Pharma offers its products under brands such as Adalat, Adempas, Aleve, Adengo, Nebido, Xarelto, Xofigo, Yasmin, YAZ among others. It operates through its research and development facilities in Germany, France, China and the US. Bayer HealthCare is headquartered in Berlin, Germany.

Scope

• Detailed information on Bayer Healthcare Pharmaceuticals required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Bayer Healthcare Pharmaceuticals in the form of a SWOT analysis
• An in-depth view of the business model of Bayer Healthcare Pharmaceuticals including a breakdown and examination of key business segments
• Intelligence on Bayer Healthcare Pharmaceuticals's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Bayer Healthcare Pharmaceuticals, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Bayer Healthcare Pharmaceuticals and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Bayer Healthcare Pharmaceuticals as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Bayer Healthcare Pharmaceuticals's business structure, strategy and prospects.

Contents

Company Snapshot
Bayer Healthcare Pharmaceuticals: Company Overview
Bayer Healthcare Pharmaceuticals: Overview and Key Facts
Bayer Healthcare Pharmaceuticals: Overview
Bayer Healthcare Pharmaceuticals: Key Facts
Bayer Healthcare Pharmaceuticals: Key Employees
Bayer Healthcare Pharmaceuticals: Major Products and Services
Bayer Healthcare Pharmaceuticals: Company History
Bayer Healthcare Pharmaceuticals: Management Statement
Bayer Healthcare Pharmaceuticals: Locations and Subsidiaries
Bayer Healthcare Pharmaceuticals: Key Competitors
Bayer Healthcare Pharmaceuticals: Company Analysis
Bayer Healthcare Pharmaceuticals: Business Description
Bayer Healthcare Pharmaceuticals: SWOT Analysis
Bayer Healthcare Pharmaceuticals: SWOT Overview
Bayer Healthcare Pharmaceuticals: Strengths
Bayer Healthcare Pharmaceuticals: Weaknesses
Bayer Healthcare Pharmaceuticals: Opportunities
Bayer Healthcare Pharmaceuticals: Threats
Bayer Healthcare Pharmaceuticals: Corporate Financial Deals Activity
Bayer Healthcare Pharmaceuticals: Financial Deals Overview
Bayer Healthcare Pharmaceuticals: Targets and Partners
Bayer Healthcare Pharmaceuticals: Top Deals 2014 - 2018YTD*
Bayer Healthcare Pharmaceuticals: Partnership
Bayer Healthcare Pharmaceuticals: Recent Developments
Bayer Healthcare Pharmaceuticals: News and Events Summary
Bayer Healthcare Pharmaceuticals: Corporate Governance
Bayer Healthcare Pharmaceuticals: Market Developments
Bayer Healthcare Pharmaceuticals: Red Flags/DistressSignals
Bayer Healthcare Pharmaceuticals: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Bayer Healthcare Pharmaceuticals: Key Facts
Table 2: Bayer Healthcare Pharmaceuticals: Key Employees
Table 3: Bayer Healthcare Pharmaceuticals: Locations and Subsidiaries
Table 4: Bayer Healthcare Pharmaceuticals: Key Competitors
Table 5: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (2014 - YTD2018)
Table 6: Bayer Healthcare Pharmaceuticals: Targets and Partners
Table 7: Bayer Healthcare Pharmaceuticals: Top Deals 2014 - 2018YTD
Table 8: Bayer Healthcare Pharmaceuticals: Partnership Volume and Value Trend (2014 - YTD2018)
Table 9: Bayer Healthcare Pharmaceuticals: Partnership Trend by Deal Type (2014 - YTD2018)
Table 10: Bayer Healthcare Pharmaceuticals: News and Events Summary
Table 11: Bayer Healthcare Pharmaceuticals: Corporate Governance
Table 12: Bayer Healthcare Pharmaceuticals: Market Developments
Table 13: Bayer Healthcare Pharmaceuticals: Red Flags/DistressSignals
Table 14: Bayer Healthcare Pharmaceuticals: Research & Development

List Of Figures

LIST OF FIGURES

Figure 1: Bayer Healthcare Pharmaceuticals: Deal Activity by Deal Type - Volume (2014 - YTD2018)
Figure 2: Bayer Healthcare Pharmaceuticals: Partnership Volume and Value Trend (2014 - YTD2018)
Figure 3: Bayer Healthcare Pharmaceuticals: Partnership Trend by Deal Type (2014 - YTD2018)